CBM2 Center for Precision Medicine: modular systems to transform liquid biopsy biomarkers
Official title: NCBIB Center of BioModular Multiscale Systems (CBM2) for Precision Medicine
Funded at University of Kansas Lawrence · NIH-11336088 · Data updated 2026-11-12
A national lab network is building modular, multi-omics tech to better analyze liquid biopsy markers for personalized medicine.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Lawrence NIH-funded |
| Lab location | 1 site (Lawrence, United States) |
| Project start | September 16, 2015 |
| Project end | March 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $1,546,623 |
| NIH project number | 2P41EB020594-12 |
| Project ID | NIH-11336088 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with diseases where liquid biopsy biomarkers are informative (e.g., cancer) who could participate in future translational or validation studies using enhanced biomarker platforms.
✕Less likely to help
Patients without diseases where liquid biopsy markers are informative or those not undergoing related diagnostic workflows may not directly benefit.
What this research studies
This grant funds the development of advanced bioModular systems designed to isolate and analyze disease-linked biomarkers from liquid biopsies. The approach aims to overcome current limits in mass input and data complexity to enable multi-omics profiles from small samples. Researchers will create platform technologies that can process circulating biomarkers with high sensitivity, potentially supporting earlier and more precise medical decisions for patients. The work is centered at the University of Kansas and involves collaboration to translate these tools toward clinical use.
Why it matters
Potential benefit: If successful, patients could benefit from more accurate, minimally invasive diagnostics and more personalized treatment strategies based on comprehensive liquid biopsy data.
How similar studies have gone: Previous work in liquid biopsy platforms shows promise but integrating multi-omics with low-input samples remains challenging and is an area of active development.
Where this research is happening
-
University of Kansas Lawrence
Lawrence, United States Active
Researchers
- Principal investigator: Soper, Steven Allan — University of Kansas Lawrence
- Study coordinator: Soper, Steven Allan
Related research
Other NIH-funded projects on the same topics.
-
KC Youth Violence Prevention Center: A comprehensive plan to reduce youth violence
A program in Kansas City aims to reduce youth violence and deaths by applying a coordinated, community-focused approach.
-
Gene regulation and the genetic basis of complex traits (how our genes influence survival and trait differences)
Researchers are studying how genetic differences that affect gene regulation contribute to when and how people survive and reproduce, especially in natural populations.
-
Finding new treatments and understanding how congenital glycosylation disorders work
A research project aims to uncover how certain congenital glycosylation disorders develop and identify existing drugs that could help treat DPAGT1-CDG.
-
How ADP-ribosylation controls our antiviral defenses
Researchers are studying a cellular modification called ADP-ribosylation and how it helps the body fight viruses, with a focus on how coronaviruses interact with this process.
-
Chemoenzymatic synthesis to make biologically active molecules using enzyme libraries
A scientist team will develop enzyme-based methods to make complex drug-like molecules that could help fight cancer and other diseases.
-
DNA breaks and repair in opioid addiction
This project looks at how DNA damage and repair in brain cells may influence opioid addiction and relapse in people and animal models.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.